8-KVBIOCIK 0001787740

Valion Bio, Inc.

Name: SEC EDGAR filing 0001683168-26-007300
Creator: Valion Bio, Inc.
License: https://www.usa.gov/government-works

Material event (8-K) filed September 23, 2026.

Current report announcing a material event, such as an acquisition, executive change, or earnings release.

Open the filing on SEC.gov

New to the 8-K? What it is and how to read one

Filing facts

Accession number: 0001683168-26-007300
Filer: Valion Bio, Inc.
Ticker: VBIO
CIK: 0001787740
Form type: 8-K
Form description: Material event
Filed at: September 23, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 23, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Valion Bio, Inc.

PRE 14ASEC filingOct 2, 2026

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1787740/000168316826007300/0001683168-26-007300-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Valion Bio, Inc. (0001787740) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001683168-26-007300.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.